NXL Nexalin Technology, Inc.
$1.64▼ -4.09%
Healthcare
Other
After hours
$1.60▼ -2.44%
Oct 27, 4:32 PM ET
Volume 69.5K
Avg Volume (10D) 68.4K
Key Metrics & Fundamentals
Market Cap
$1.72M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.59 - 49.50
% vs 50 MA
-67.90%
% vs 200 MA
-85.35%
RSI-14
26.5
MACD Histogram
-0.0300
Beta (1Y vs SPY)
0.40
Free Cash Flow
-$1.85M
Gross Rev
$12,161
Gross Profit
$8,897
EBITDA
-$2.23M
COGS
$3,264
Operating Exp
$2.26M
Operating Income
-$2.25M
EBIT
-$2.25M
Pretax Income
-$2.24M
Net Income
-$2.24M
EPS (Diluted)
-0.11
Price & Volume History
Loading chart…
Recent News
Nexalin Technology Announces Fourth Peer-Reviewed Publication in Alzheimer's Disease: 15 mA DIFS™ Significantly Improves Sleep Quality in Patients with Mild Alzheimer's Disease
GlobeNewswire · Oct 27, 2026 9:00 AM ET
Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing
GlobeNewswire · Oct 8, 2026 8:30 AM ET
Top Midday Gainers
MT Newswires · Oct 1, 2026 2:33 PM ET
BC-Most Active Stocks
Associated Press · Oct 1, 2026 10:30 AM ET
Nexalin Technology Signs South America Distribution Agreement for Nexalin Sync Commercialization
InvestorsHub · Oct 1, 2026 10:03 AM ET
Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation
GlobeNewswire · Oct 1, 2026 8:30 AM ET
Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy
GlobeNewswire · Sep 29, 2026 9:00 AM ET
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
ACCESS Newswire · Sep 11, 2026 9:00 AM ET
Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to Guide Design of Planned U.S. Alzheimer’s Pilot Study
GlobeNewswire · Sep 3, 2026 8:30 AM ET
Nexalin Technology Announces Reverse Stock Split
GlobeNewswire · Aug 27, 2026 7:25 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See NXL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.